Chinese Biotech Financing Rebounds But Mega Deals Missing

 
• By Dexter Jie Yan
  
funding
The $100m mark was still out of reach for most Chinese biotechs seeking funds. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia